文献速递儿童口腔牙体牙髓病

三种生物活性牙髓水泥在乳磨牙可逆性牙髓炎间接盖髓中的随机对照试验:1年随访

A randomized controlled clinical trial of the performance of three bioactive endodontic cements in primary molar teeth diagnosed with reversible pulpitis: 1-year follow-up study.
PubMed 文献 · J Dent · 2024-10-09

这项随机对照临床试验纳入86颗未经治疗的乳磨牙,比较三种生物活性牙髓水泥(新型释放氟的波特兰水泥基材料、树脂改性硅酸玻璃水泥、纯硅酸三钙基水泥)间接盖髓的临床与影像学成功率。1年随访显示成功率分别为100%、88.5%和88%,组间差异无统计学意义(P>0.05)。新型释放氟的波特兰水泥基材料可作为保存乳磨牙的替代选择。

要点

  • 三种生物活性牙髓水泥间接盖髓治疗乳磨牙可逆性牙髓炎1年成功率均较高。
  • 新型释放氟的波特兰水泥基材料组成功率达100%,与其余两组无统计学差异。
  • 树脂复合修复体完整性按USPHS标准在三组间无差异。

核心结论

  • 新型释放氟的波特兰水泥基材料在乳磨牙可逆性牙髓炎间接盖髓治疗中成功率高,可作为保存乳牙的替代选择。

研究设计与样本

  • 随机对照临床试验纳入86名参与者,每名参与者包含一颗未经治疗的第一或第二乳磨牙,随机分入三组。
  • 三组分别使用纯硅酸三钙基水泥、树脂改性硅酸玻璃水泥和新型释放氟的波特兰水泥基材料进行间接盖髓。
  • 在1、6和12个月进行临床与影像学评估,数据分析采用Pearson卡方、Kruskal-Wallis H和Z检验(P=0.05)。

主要发现

  • 纯硅酸三钙基水泥组成功率为88%(n=25),树脂改性硅酸玻璃水泥组为88.5%(n=26),新型释放氟的波特兰水泥基材料组为100%(n=25)。
  • 第1、6和12个月随访时三组间差异均无统计学意义(P>0.05)。
  • 根据USPHS标准,覆盖于三种水泥上的树脂复合修复体完整性无差异。

关键数值与推荐

  • 纯硅酸三钙基水泥组成功率88%(n=25)。
  • 树脂改性硅酸玻璃水泥组成功率88.5%(n=26)。
  • 新型释放氟的波特兰水泥基材料组成功率100%(n=25)。
  • 三组各随访时间点成功率差异无统计学意义(P>0.05)。
  • 树脂复合修复体完整性按USPHS标准三组间无差异。

临床怎么用

  • 对乳磨牙可逆性牙髓炎可考虑使用新型释放氟的波特兰水泥基材料行间接盖髓以保存活髓。
  • 三种生物活性牙髓水泥在1年随访中均表现出较高的成功率,临床选择可综合考虑材料特性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this clinical trial was to evaluate and compare the clinical and radiographic successes of three bioactive endodontic cements (BEC) including novel portland cement-based material releasing fluoride, resin-modified silicate glass cement, and pure tricalcium silicate-based cement-in the treatment of primary molars diagnosed with reversible pulpitis via indirect pulp capping. METHODS: Eighty-six (86) participants with previously untreated first and second primary molars were included in this study. The teeth were randomly allocated into three groups: pure tricalcium silicate-based cement, resin-modified silicate glass cement, and novel portland cement-based material releasing fluoride. Cavities were capped with the assigned cement after caries excavation using standard protocols. The teeth that underwent treatment were restored using glass ionomer cement and composite resin. Clinical and radiographic evaluations were performed at 1, 6, and 12 months. The data were analyzed using Pearson chi-square, Kruskal-Wallis H and Z test (P = 0.05). RESULTS: The success rate was 88 % (n = 25) in the pure tricalcium silicate-based cement group, 88.5 % (n = 26) in the resin-modified silicate glass cement group, and 100 % (n = 25) in the novel portland cement-based material releasing fluoride group. The differences at the 1st, 6th, and 12th month follow-up visits were not statistically significant among the groups (P > 0.05). No difference was found between the integrity of the resin composite restorations overlying pure tricalcium silicate-based cement, resin-modified silicate glass cement, and novel portland cement-based material releasing fluoride according to the USPHS criteria. CONCLUSIONS: Novel portland cement-based material releasing fluoride can be considered an alternative for preserving the tooth, as it showed a high success rate in treating primary molars diagnosed with reversible pulpitis via indirect pulp capping. CLINICAL SIGNIFICANCE: Novel Portland cement-based material releasing fluoride could be beneficial in the treatment of primary molars diagnosed with reversible pulpitis via indirect pulp capping.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Kayaci ŞT, Yazici ZS, Kınıkoğlu İ, et al. A randomized controlled clinical trial of the performance of three bioactive endodontic cements in primary molar teeth diagnosed with reversible pulpitis: 1-year follow-up study. J Dent. 2024. PMID: 39384060. doi:10.1016/j.jdent.2024.105378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。